Stocks · Health care · Pharmaceutical Preparations

Janux Therapeutics, Inc.

JANX Clue Score43

United States Fiscal year ends December CIK 0001817713 Results filed 5 Nov 2026

Add to watchlist

What the insiders did Net selling

Bought (12 mo)

$0.00

out of their own pocket, the only kind of buying there is

Sold (12 mo)

$557.06K

$0.00 on a plan · $209.92K straight out of an exercise

Sold at will

$347.15K

8 of 11 sales

Net

−$557.06K

−$347.15K against sales at will